Cyclosporin a therapy in patients with primary Sjogren's syndrome: results at one year

Απλή σελίδα τεκμηρίου
dc.contributor.authorDrosos, A. A.en
dc.contributor.authorSkopouli, F. N.en
dc.contributor.authorGalanopoulou, V. K.en
dc.contributor.authorKitridou, R. C.en
dc.contributor.authorMoutsopoulos, H. M.en
dc.date.accessioned2015-11-24T19:25:45Z
dc.date.available2015-11-24T19:25:45Z
dc.identifier.issn0301-3847-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22651
dc.rightsDefault Licence-
dc.subjectClinical Trials as Topicen
dc.subjectCyclosporins/adverse effects/*therapeutic useen
dc.subjectDouble-Blind Methoden
dc.subjectHumansen
dc.subjectSjogren's Syndrome/*drug therapyen
dc.titleCyclosporin a therapy in patients with primary Sjogren's syndrome: results at one yearen
heal.abstractWe present our experience with small doses of cyclosporine A (CyA), 5 mg/kg/day, in patients with primary Sjogren's syndrome treated for up to 12 months. Subjective improvement in xerostomia occurred at 6 months of treatment, without objective improvement in any sicca parameters. At 12 months, xerostomia improved slightly, but minor salivary gland histology worsened. We conclude that small doses of CyA in patients with primary Sjogren's syndrome for up to 12 months are rather ineffective.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/3296152-
heal.journalNameScand J Rheumatol Supplen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate1986-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ